New eye drops aim to halt blinding disease in seniors
Disease control
Recruiting now
This study tests whether GAL-101 eye drops can slow the growth of geographic atrophy, a form of advanced age-related macular degeneration that causes blind spots. About 110 adults aged 55 and older with early-stage atrophy will use the drops or a placebo daily for up to two years…
Phase: PHASE2 • Sponsor: Galimedix Therapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC